cronos group glp-1 receptor agonists weight management diabetes treatments as for Type 2 Breakthrough of the Year: GLP-1

The capability of GLP-1RAs to cross the bloodbrain barrier suggests that the physiological role of these agents may extend beyond that of glucose homeostasis and food intake as a potential pharmacotherapy for NUD [21]

LZ: Funding acquisition, Supervision, Validation, Writing review and editing

Regulatory expectations, manufacturing feasibility, clinical trial design, and commercial differentiation play decisive roles in determining whether a biologically compelling peptide ultimately reaches patients

As such, time-to-event analyses were not performed but may be considered in future studies with longer follow-up durations

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

Horm Metab Res (1995) 27(8):3725